Healthcare & Life Sciences
Atavistik Bio
Atavistik Bio is a Healthcare & Life Sciences startup, most recent round Series B, 2 tracked investors.
Activeseries-b
series-b
Stage
2
Investors
About Atavistik Bio
Atavistik Bio is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Atavistik Bio is a clinical-stage biotechnology company developing selective allosteric small-molecule therapeutics targeting disease-causing proteins, with lead programs for Hereditary Hemorrhagic Telangiectasia and myeloproliferative neoplasms.
Explore Atavistik Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.